Panacea Biotec Limited (NSE:PANACEABIO)

bluebird bio Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 4, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	25,229	27,027	7,445	6,643	9,077	10,958
Market Cap Growth	263.02%	263.02%	12.08%	-26.82%	-17.16%	63.75%
Enterprise Value	24,308	25,428	5,776	3,942	15,905	16,321
Last Close Price	411.90	441.25	121.55	108.45	148.20	178.90
PE Ratio	-	-	-	-	0.84	-
PS Ratio	4.51	4.83	1.33	1.44	1.37	1.75
PB Ratio	3.04	3.25	0.89	0.79	1.04	-4.73
P/TBV Ratio	3.18	3.41	0.94	0.82	1.08	-
P/FCF Ratio	-	-	-	-	-	12.91
P/OCF Ratio	-	-	-	-	-	10.28
EV/Sales Ratio	4.35	4.55	1.03	0.86	2.40	2.61
EV/EBITDA Ratio	-	-	-	-	-	18.70
EV/EBIT Ratio	-	-	-	-	-	38.19
EV/FCF Ratio	-31.29	-	-	-	-	19.23
Debt / Equity Ratio	0.03	0.03	0.03	0.02	0.04	-3.54
Debt / EBITDA Ratio	-	-	-	-	-	9.37
Debt / FCF Ratio	-	-	-	-	-	9.65
Asset Turnover	0.44	0.44	0.45	0.30	0.45	0.49
Inventory Turnover	1.02	1.02	1.21	1.22	1.36	1.27
Quick Ratio	0.50	0.50	0.70	0.83	0.82	0.41
Current Ratio	1.49	1.49	1.57	1.71	1.28	1.14
Return on Equity (ROE)	-1.04%	-1.04%	-0.18%	-3.94%	335.95%	-
Return on Assets (ROA)	-3.00%	-3.00%	-2.06%	-4.24%	-2.06%	2.08%
Return on Capital (ROIC)	-4.43%	-4.43%	-3.01%	-7.26%	-4.05%	3.50%
Return on Capital Employed (ROCE)	-	-	-	-	-	5.90%
Earnings Yield	-0.33%	-0.31%	-0.16%	-5.00%	118.79%	-13.48%
FCF Yield	-3.08%	-2.87%	-10.45%	-69.76%	-13.33%	7.75%
Buyback Yield / Dilution	0.25%	0.25%	-	-	-	-

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.